GLP-1: Glucagon-Like Peptide-1, a hormone that regulates appetite and blood sugar.
GIP: Glucose-dependent Insulinotropic Polypeptide, a hormone that works alongside GLP-1 to regulate metabolism.
Semaglutide: The active ingredient in Wegovy, a GLP-1 medication.
Tirzepatide: The active ingredient in Mounjaro, a dual GLP-1/GIP medication.
Titration: The process of gradually increasing your medication dose to minimise side effects.
BMI: Body Mass Index, a measurement using height and weight to estimate body fat.
Subcutaneous injection: An injection into the fatty tissue under the skin.
Maintenance: The phase of treatment focused on sustaining your weight loss results.
Body Transformation Programme: Compound's comprehensive weight management programme combining medication and the Compound Code.
Pen device: The pre-filled injection device used to administer your medication.
Dosage strength: The concentration of medication in your pen (e.g., 0.25mg, 0.5mg).
Care Team: The healthcare professionals supporting your weight loss journey.
Prescriber: The qualified healthcare professional who assesses your suitability and prescribes your medication.